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Prevalence of alcohol use in late pregnancy
Amna Umer1, Christa Lilly2, Candice Hamilton1, Aileen Baldwin3, Janine Breyel4, Amy Tolliver4, Christina Mullins5, Collin John1 and
Stefan Maxwell6
BACKGROUND: Prenatal alcohol exposure (PAE) can result in detrimental developmental complications. The objective of this study
was to estimate the most recent PAE prevalence data for the state of West Virginia (WV) and associated factors.
METHOD: In all, 1830 newborn residual dried blood spots (DBS) in the WV Newborn Screening Repository were analyzed for
phosphatidylethanol (PETH). Data were matched with Project WATCH data (94% match, N= 1729).
RESULTS: The prevalence of late pregnancy PAE was 8.10% (95%CI: 6.81, 9.38) for all births, 7.61% (95%CI: 6.26, 8.97) for WV
residents only, and ranged from 2.27 to 17.11% by region. The signiﬁcant factors associated with PAE included smoking (OR: 2.03,
95% CI: 1.40, 2.94), preterm births (OR: 1.88; 95% CI: 1.23, 2.89), birth weight of ≤2000 g vs. >3000 g (OR: 2.62, 95%CI: 1.19, 5.79), no
exclusive breastfeeding intention (OR: 1.45, 95% CI: 1.02, 2.04), and not exclusively breastfeeding before discharge (OR: 1.61; 95% CI:
1.09, 2.38).
CONCLUSION: The prevalence of PAE is higher than previously shown for the state. Accurate and timely estimates are vital to
inform public health workers, policymakers, researchers, and clinicians to develop and promote effective prevention strategies to
lower PAE prevalence and provide targeted interventions and treatment services for infants affected by PAE.
Pediatric Research _#####################_ ; https://doi.org/10.1038/s41390-019-0731-y
INTRODUCTION
Maternal alcohol use in pregnancy negatively impacts several
organ systems of the developing embryo and fetus.1 The severity
of the outcomes varies by dose, duration, and the developmental
stage of the embryo.1 There is a broad range of deﬁcits associated
with prenatal alcohol exposure (PAE) referred to as fetal alcohol
spectrum disorders (FASD).1 FASD includes the fetal alcohol
syndrome (FAS), which is the most severe and speciﬁc outcome
associated with high-dose ethanol exposure in the ﬁrst trimester
during organogenesis. This includes but is not limited to growth
deﬁciency, developmental delay, craniofacial malformations, and
intellectual disabilities as described in 1973 by Smith and Jones.2–4
In the third trimester, after the phenotype has been established
and the critical period of organogenesis is mainly complete, there
is a period of rapid brain growth. Alcohol exposure during this
period is associated with a range of developmental problems that
may not be overtly expressed as morphological deformities. These
include developmental problems, such as difﬁculties with visual-
spatial learning, language, executive functioning, attention and
focusing, memory skills, auditory comprehension, reaction time,
and organizing or sequencing tasks.5 A recent US study among
ﬁrst-grade children [mean age 6.7 years (SD, 0.41)] in four US
communities estimated the prevalence of FASD ranging from 1.1
to 5.0%.6 As PAE can have detrimental consequences at various
gestational stages, there is no safe amount of alcohol intake
throughout pregnancy,5 and complete abstinence is recom-
mended.7 Though the outcomes and guidelines for alcohol use
in pregnancy are well-established, the most recent National
Survey on Drug Use and Health (NSDUH) self-reported survey for
the years 2016–2017 showed a high prevalence of PAE in the
United States (US).8 Nearly 11.5% of pregnant women drank any
amount of alcohol in the past 30 days and the estimated incidence
of prenatal binge drinking (deﬁned as ≥4 or more alcoholic drinks
on the same occasion on at least 1 day in the past month) was
5.2%.8
West Virginia (WV) is a primarily rural Appalachian state in the
US and has high rates of chronic diseases, substance use disorder,
and smoking during pregnancy relative to the rest of the nation.
Based on the Pregnancy Risk Assessment Monitoring System
(PRAMS) 2015 survey, 2.7% of women in WV reported drinking
alcohol during their last 3 months of pregnancy.9 However, PRAMS
is a self-reported telephone survey, and this method has shown to
underestimate the prevalence of alcohol consumption by more
than one third.10 Currently, there are no standard laboratory tests
that can deﬁnitively detect alcohol use in pregnancy due to its
rapid metabolism; thus, testing maternal blood, breath, or urine is
only useful for alcohol exposure within the previous 24 h.11
Phosphatidylethanol (PETH) is a direct metabolite formed from
alcohol (ethanol) consumption, manifesting as a phospholipid
incorporated into the membranes of red blood cells.12 PETH from
dried blood spots (DBS) has been shown to be a valuable test with
a high degree of sensitivity for assessing PAE at birth.12–15 PETH
has a long half-life of 3–5 days and a positive PETH value is
indicative of late pregnancy PAE (2–4 weeks).12–16 Although there
is a positive linear correlation between degree of alcohol
consumption and PETH concentrations, there have been no
established PETH cutoffs that differentiate various levels of alcohol
consumption (low vs. moderate vs. heavy) during pregnancy.17 In
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2009, an umbilical cord tissue study was conducted at eight
hospitals in WV to estimate the rate of intrauterine substance
exposure (IUSE) in the state. The study tested the tissue for various
drug metabolites including PETH for late pregnancy PAE. The
results showed that the prevalence of late pregnancy PAE across
the eight hospitals was 5.1%.18 A recent study in Texas using the
newborn residual DBS found 8.4% of the sample was positive for
PETH (>20 ng/ml).13
Due to screening and diagnostic complexities for alcohol use in
pregnancy, there are limited data on the statewide prevalence of
PAE for WV. Self-reported surveillance systems such as PRAMS
certainly underestimate the true prevalence rate of prenatal
alcohol use, and the WV umbilical cord tissue study was
conducted a decade ago from a limited number of hospitals.
The objective of this study was to estimate the most recent
prevalence data on late pregnancy PAE in the state of WV by
screening newborn residual DBS. This method has shown to be
sensitive and cost-effective when estimating prevalence of PAE in
late pregnancy at a population-level.13,19 The prevalence data
were compared to other estimated prevalence data for the state.
The secondary aim of the study was to examine maternal and
infant sociodemographic and health-related characteristics asso-
ciated with PAE. There is increasing scientiﬁc evidence that up to
5% of children born in the US each year will demonstrate
developmental disabilities related to FASD during early childhood.
Thus, assessing the extent and nature of PAE as one of the most
preventable cause of birth defects can have signiﬁcant policy
implications for the health and wellbeing of the newborns in the
state of WV.
METHODS
Data collection
Dried blood spot specimens. As part of the Newborn Screening
Program, DBS cards are collected from all newborns from all
birthing centers in WV and mailed to the WV Ofﬁce of Laboratory
Services (OLS) within 24 h after collection. The details of the data
collection process are provided elsewhere.20
Study sample. To calculate the sample size needed for this study,
we powered the study both for the precision of the prevalence
estimate for the state of WV and for testing the prevalence rate
relative to the other methods previously used (self-report and
umbilical cord). These sample size estimates between 1105 and
1825 for detecting 8−5% prevalence meet or exceed the sample
size necessary for testing a noninferiority test (i.e., showing "as
good as or better") assessing the proportion of populace testing
positive for alcohol use, using the new method as compared to
umbilical cord. This study was approved by the West Virginia
University IRB (protocol, #1712902480). The ﬁnal study sample
included randomly selected 610 DBS cards from each of the
months of November (2017), December (2017), and January (2018)
for a total of 1830 DBS from the state newborn screening
repository of WV OLS. The newborn DBS cards were transferred to
the Project WATCH ofﬁce (aka West Virginia Birth Score) at West
Virginia University. The Birth Score team provided a unique
identiﬁer for each DBS card that was separated at the dotted line
from the newborn screening card that contained the newborn’s
identifying information. The deidentiﬁable portion of the card
containing the blood spots was sent to the United States Drug
Testing Laboratories, Inc. (USDTL) for PETH analysis.
Project WATCH. Project WATCH is a WV statewide mandate since
1998 (House Bill 2388). The project collects surveillance data on
every infant born in all WV birthing hospitals/facilities to identify
infants who are at a higher risk of infant mortality the ﬁrst year of
life, in order to initiate close follow-ups. More information about
this project can be found elsewhere.21 USDTL sent the PETH-DBS
lab results to the Project WATCH ofﬁce in mid-to-late 2018. The
USDTL ﬁle was matched with the Project WATCH ﬁle using the
infant’s last name and birth date. This matched 1709 records
(92.98%). The remaining data were hand matched for another 20
infants, which made a total of 1729 matched out of the 1830 cases
(94.17%).
Measures
PETH analysis. PETH is a long-term biomarker of alcohol
ingestion, which can be detected and measured in the DBS,13
and indicates PAE in the month prior to birth.12 The DBS
specimens were analyzed at USDTL using previously published
methods.22 The limit of detection (LOD) was 2 ng/ml; the limit of
quantitation (LOQ) was 8 ng/ml and the assay was linear up to
200 ng/ml. For this study, given no amount of alcohol has been
established as safe during pregnancy, a positive PETH result was
deﬁned as the LOQ of a reading of ≥ 8 ng/ml or 0.08 g in 100ml.
The cutoff was based on the works of Jones et al.22 and Baldwin
et al.12 on alcohol detection in the DBS by USDTL. Other
researchers have also used PETH cutoff at ≥ 8 ng/ml to indicate
a positive and moderate to heavy alcohol use in the last month of
pregnancy.14,16,23 Using this analytical cutoff, we can capture all
data for any exposure with a high degree of sensitivity and
speciﬁcity.
Project WATCH data. Maternal factors from Project WATCH
included: (1) maternal age (<19 and ≥19), race (white and others),
education (≤10 grades and ≥11 grades), health insurance status
(Medicaid and Private), smoking during pregnancy (yes/no),
feeding intention (breast only, bottle or both), gestational age
(preterm and term), and number of previous pregnancies (0 and
≥1). The infant variables included birth weight (≤2000, 2001–2500,
2501–3000, and >3000 g), IUSE (yes/no), neonatal abstinence
syndrome (NAS) (yes/no), infant exclusively breastfed before
hospital discharge (yes/no), and NICU admission (yes/no).
Region. WV consists of 55 counties, which are divided into six
Substance Abuse and Mental Health Services Administration
(SAMHSA) regions. SAMHSA works with the state substance abuse
and mental health agency to deﬁne substate regions that meet
the state needs and reporting requirements while ensuring the
sample size for the NSDUH is large enough to provide estimates
with adequate precision.24 These substate regions were created to
understand the geographic variability of substance use data
within each state in order to provide vital information for
planning, reporting, program development, prevention and
intervention efforts, and allocation of funds to areas in need for
services.24 The substance use data are mostly analyzed using
these regions due to the availability of resources and services in
the counties clustered together in one region. This substate
regional variable was created from the Project WATCH data that
contains county-level information of the mother at the time of
delivery.
Analysis
Analysis for this project included the proportion with high PETH
(≥8 ng/ml) for the total sample of all births in the state of WV, WV
residents’ only, and by WV SAMHSA regions, with alpha set to 0.05.
Exact conﬁdence intervals (CI) are also reported. We also present
the sociodemographic characteristics of the entire sample and
also by six SAMSHA regions. Logistic regression analysis was
conducted to examine the bivariate association between late
pregnancy PAE and several maternal and infant characteristics and
presented as odds ratio (OR) along with 95% CIs.
The prevalence rates for the state were also tested against
known values from other studies using noninferiority testing, with
the research hypothesis that the estimate would be higher or the
same as other methodologies that may underestimate the true
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prevalence rates.25 Noninferiority testing is a statistical methodol-
ogy where one tries to demonstrate similarity rather than
difference to an established result.25 Speciﬁcally, noninferiority
testing tests the research hypothesis that the new method or
therapy is equivalent or superior (i.e., “as good as or better”, or not
inferior) to the current one, and the null hypothesis that it is
inferior.26 Thus, the series of noninferiority tests were run by the
binomial test of one proportion against the primary hypothesis
value based on the WV 2009 umbilical cord study (5.1%)18 as well
as proportions found by self-reported PRAMS state data (WV data;
3.7%)9 and by a similar study in a different state (8.4% with
>20 ng/ml, 24.7% with ≥ 8 ng/ml),13 with a margin of 3% and
alpha set to 0.05. Results within the lower conﬁdence interval
margin of 3% and larger would establish equivalence or super-
iority to the previously established prevalence rates (i.e., the
method would be as “good as or better than” the methods which
resulted in the previously reported prevalence). Anything below
the 3% lower conﬁdence interval margin would be considered
“inferior” or within the null hypothesis.
Four post-hoc analyses were performed to understand and
explain the study ﬁndings. These include (1) logistic regression
analyses to examine the association of late pregnancy PAE and
birth weight in data restricted to full-term births only (n= 1498,
87%, (2) logistic regression analyses to examine the association of
late pregnancy PAE and term birth stratiﬁed by infant sex, (3)
calculate the proportion of alcohol use data captured within the
substance use data collected by Project WATCH and (4) examine
the prevalence of PAE using a higher cutoff of >20 ng/ml, as
conducted by Bakhireva et al. for comparison purposes.13
RESULTS
The ﬁnal sample size was 1729. The prevalence of late pregnancy
PAE (PETH ≥8 ng/ml) was 140 cases or 8.10% (95% CI: 6.81, 9.38) in
the entire sample that included out-of-state residents as well. The
positive PETH concentrations ranged from 8 to 346 ng/ml with a
mean positive PETH concentration of 20.7 ng/ml (SD= 34.6).
Nearly 15% of infants were born to mothers who lived in the
surrounding states of Kentucky, Maryland, Ohio, Pennsylvania, and
Virginia but gave birth in the state of WV.
The prevalence of late pregnancy PAE for WV residents only and
according to the six predeﬁned SAMSHA regions along with 95%
CI are presented in Table 1. For WV residents only, the prevalence
of late pregnancy PAE was 7.61% (95% CI: 6.26, 8.97) and the
regional prevalence ranged from 2.27 to 17.11% (Fig. 1). Region 3
had one of the highest prevalence rates of late pregnancy PAE in
the state. Table 2 provides the descriptive characteristics of the
study population along with unadjusted OR and 95% CI of PAE
and maternal and infant factors for the full dataset (N= 1,729).
The descriptive characteristics of the study population by six
SAMSHA regions are given in Table 3.
Next, we compared the prevalence of late pregnancy PAE
established in this study (7.61%) against several other prevalence
rates found using other methods, with the noninferiority research
hypothesis that the prevalence would be “as good as or better
than” the previously found prevalence rates, assuming these
previous rates are underestimating the true prevalence. Results of
the noninferiority testing demonstrate this testing method with a
proportion of 7.61% to be “as good as or better than” the
umbilical (p0= 5.1%) and self-report testing (p0= 2.7%) pre-
viously done, and “as good as or better than” the Texas state data
utilizing the same method but with the >20 ng/ml cutoff (p0=
8.4%), all p < 0.0001, within the 3% margin. However, noninfer-
iority testing showed our prevalence rate was not “as good or
better than” relative to the Texas state data using the equivalent
LOQ cutoff of ≥ 8 ng/ml (p0= 24.7%), p= 1.00.
The statistically signiﬁcant factors associated with PAE included
smoking during pregnancy, birth weight, gestational age, and
breastfeeding intent and practice. The odds of smoking during
pregnancy was twice in mothers with prenatal alcohol use vs. no
use (OR: 2.03, 95% CI: 1.40, 2.94). The odds of having a preterm
birth was also nearly twice among pregnant women with prenatal
alcohol use vs. no use (OR: 1.88; 95% CI: 1.23, 2.89). Only one birth
weight category was signiﬁcantly associated with PAE [birth
weight of ≤2000 g vs. >3000 g (OR: 2.62, 95%CI: 1.19, 5.79)]. The
odds of not intending to exclusively breastfeed and not
exclusively breastfeeding the newborn before hospital discharge
was 2.62 (95% CI: 1.19, 5.79) and was 1.61 times (95% CI: 1.09, 2.38)
among those with PAE vs. no exposure respectively.
The result of the post-hoc analysis for data restricted to full-term
birth infants only showed that late PAE was not signiﬁcantly
associated with low birth weight (LBW) of <2500 g compared to
>3000 g (Table 2). The second analysis for the association between
PAE and preterm vs. term birth stratiﬁed by infant’s sex. In female
infants the association was not statistically signiﬁcant (OR: 1.85
95% CI: 0.95, 3.61, p= 0.0717) and in male infants this association
was statistically signiﬁcant (OR: 1.89 95% CI: 1.08, 3.31, p= 0.0269).
The third post-hoc analysis showed that among all those infants
with IUSE, 9.09% were positive for PAE. The IUSE did not capture
90.91% of the alcohol cases. Lastly, the prevalence of PAE in the
Table 1. State and SAMHSA regions frequencies, valid percentages, prevalence of late prenatal alcohol use (high PETH ≥8 ng/ml) and 95%
conﬁdence intervals.
SAMHSA region N Sample size by
region (%)
Frequency for high
PETH
Binomial proportion for
high PETH (%)
95% lower conﬁdence
interval
95% upper conﬁdence
interval
State 1471 — 112 7.61 6.26 8.97
1 92 6.25 7 7.61 2.19 13.03
2 132 8.97 3 2.27 0.00 4.82
3 152 10.33 26 17.11 11.49 24.05
4 364 24.75 17 4.67 2.50 6.84
5 424 28.82 27 6.37 4.04 8.69
6 307 20.87 32 10.42 7.01 14.40
Region 1: Brooke, Hancock, Marshall, Ohio, Wetzel
Region 2: Berkeley, Grant, Hampshire, Hardy, Jefferson, Mineral, Morgan, Pendleton
Region 3: Calhoun, Jackson, Pleasants, Ritchie, Roane, Tyler, Wirt, Wood
Region 4: Barbour, Braxton, Doddridge, Gilmer, Harrison, Lewis, Marion, Monongalia, Preston, Randolph, Taylor, Tucker, Upshur
Region 5: Boone, Cabell, Clay, Kanawha, Lincoln, Logan, Mason, Mingo, Putnam, Wayne
Region 6: Fayette, Greenbrier, McDowell, Mercer, Monroe, Nicholas, Pocahontas, Raleigh, Summers, Webster, Wyoming
Bold: State average
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month prior to birth using a higher cutoff of PETH > 20 ng/ml was
31 cases or 1.79% (95% CI: 1.17, 2.42) in the entire sample that
included out-of-state residents as well.
DISCUSSION
Alcohol use during pregnancy is a signiﬁcant public health issue
globally, nationally, and also in the state of WV. This study used
data from a sample of all residual DBS cards of infants born in the
state from November 2017 to January 2018 to examine the
prevalence of PAE using PETH. The results demonstrated that PAE
in the last month prior to delivery was 8% among all births and
7.6% among WV residents. These prevalence rate of late
pregnancy PAE is much higher than what was previously known
for the state of WV.
The previous prevalence estimates for PAE for WV are from two
sources. The ﬁrst source is the PRAMS data from year 2015. These
data are a self-reported telephone survey that asked women, (1) if
they drank alcoholic drinks in the past 2 years; (2) if they drank
alcohol 3 months before pregnancy; and (3) if they drank alcohol
during the last 3 months of pregnancy. The result of the survey
showed that 59.3% women drank in the past 2 years prior to
pregnancy, 52.2% did not drink 3 months before pregnancy, and
2.7% (~1 in 40 women) drank during the last 3 months of
pregnancy in WV.9 Data show that this method of data collection
for alcohol use tends to underestimate the alcohol use prevalence
by more than one third,10 perhaps due to social desirability bias,
stigma, as well as fear of reports to Child Protective Services. The
current study prevalence (7.61%) shows improvement in estima-
tion over this previous self-report study (noninferiority p < 0.0001).
The second source is a study conducted in eight diverse birthing
hospitals in WV in 2009 using PETH in the umbilical cord tissue.
The results from the umbilical cord tissue showed that on average
1 in 20 women (~5%) drank alcohol in late pregnancy.18 The
current study showed the prevalence rates to be nearly 1 in 13
women (~8%), which is higher than what was previously reported
and is statistically signiﬁcant (noninferiority p < 0.0001). This may
be due to the methodological differences in the study designs as
well as in the data collection techniques and the type of sample
used for the analysis.
We also compared our results to the recent statewide
population base study conducted in Texas that used the same
method as our study (i.e. detection of PETH in the infant residual
DBS) and found the prevalence of PAE to be 24.7% when using a
cutoff of ≥8 ng/ml and 8.4% when using a cutoff of >20 ng/ml.13
Using the ≥8 ng/ml PETH cutoff for comparison with the Texas
study, we hypothesize that our study probably underestimated
the prevalence rates of late pregnancy PAE in WV due to increased
chance of false-negative results as a result of partial degradation
of DBS sample that were analyzed 6−8 months after data
collection. Moreover, there is no established PETH cutoff
concentration that is used for assessing PAE in newborns.27,28
Some researchers have reported values above the limit of
detection (LOD, ≥2 ng/ml) to indicate positive PAE,27 while others
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Fig. 1 Prevalence and 95% conﬁdence limits of late prenatal alcohol use by SAMHSA substate regions for West Virginia residents birth only (N
= 1471).
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Table 2. Descriptive characteristics and unadjusted odds ratios (OR) of late alcohol use during pregnancy and maternal and infant factors (N= 1729).
Perinatal factors Total Column % Alcohol use during pregnancy ORs (95% CI)
No Row % Yes Row %
Birth weight (g)
≤2000 47 2.72 39 82.98 8 17.02 2.62 (1.19−5.79)
2001−2500 111 6.42 101 90.99 10 9.01 1.27 (0.64−2.5)
2501−3000 357 20.65 323 90.48 34 9.52 1.35 (0.89−2.04)
>3000 (Ref.) 1214 70.21 1126 92.75 88 7.25 —
Health insurance
Private insurance (Ref.) 786 49.94 724 92.11 62 7.89 —
Medicaid 788 50.06 723 91.75 65 8.25 1.05 (0.73–1.51)
Intrauterine substance use
No (Ref.) 1476 85.37 1359 92.07 117 7.93 —
Yes 253 14.63 230 90.91 23 9.09 1.16 (0.73−1.86)
NAS
No (Ref.) 1649 95.37 1517 92 132 8 —
Yes 80 4.63 72 10 8 10 1.28 (0.6−2.71)
NICU admission
No (Ref.) 1613 93.29 1488 92.25 125 7.75 —
Yes 116 6.71 101 87.07 15 12.93 1.77 (0.99–3.13)
Feeding intention
Bottle or both 756 43.72 683 90.34 73 9.66 1.45 (1.02−2.04)
Breast (Ref.) 973 56.28 906 93.11 67 6.89 —
Breastfed exclusively
No 1109 64.14 1006 90.71 103 9.29 1.61 (1.09−2.38)
Yes (Ref.) 620 35.86 583 94.03 37 5.97 —
Gestational age (GA)
Preterm 231 13.36 201 87.01 30 12.99 1.88 (1.23−2.89)
Term (Ref.) 1498 86.64 1388 92.66 110 7.34 —
Size for gestational age
SGA 128 7.46 114 89.06 14 10.94 0.73 (0.36−1.48)
AGA (Ref.) 1440 83.92 1323 91.88 117 8.13
LGA 148 8.62 139 93.92 9 6.08 1.39 (0.78−2.50)
Maternal age
<19 (Ref.) 113 6.54 109 96.46 4 3.54 —
≥19 1616 93.46 1480 91.58 136 8.42 2.50 (0.91−6.89)
Maternal education
≤10 grades 139 8.04 127 91.37 62 7.89 1.05 (0.73−1.51)
≥11 grades (Ref.) 1590 91.96 1462 91.75 65 8.25 —
Previous pregnancies
0 (Ref.) 479 27.7 448 93.53 31 6.47 —
≥1 1250 72.3 1141 91.28 109 8.72 1.38 (0.91−2.09)
Smoking
No (Ref.) 1356 78.43 1264 93.22 92 6.78 —
Yes 373 21.57 325 87.13 48 12.78 2.03 (1.40−2.94)
Race
Other (Ref.) 134 7.88 124 92.54 10 7.46 —
White 1566 92.12 1440 91.95 126 8.05 1.09 (0.56−2.12)
Post-hoc analysis:
Birth weight (g) in
Term Births only (n= 1498)
≤2000 and 2001–2500a 44 2.94 40 90.91 4 9.09 1.32 (0.46–3.77)
2501–3000 277 18.49 254 90.70 23 8.30 1.19 (0.74–1.93)
>3000 (Ref.) 1177 78.57 1094 92.95 83 7.05 —
Bold ORs= Statistically signiﬁcant factors (p < 0.05)
OR odds ratio, CI conﬁdence interval, NAS Neonatal Abstinence Syndrome
aCombining rows due to low cell count: ≤2000 frequency= 2 (0.13%) merged with 2001–2500 category frequency= 42 (2.8%)
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have proposed that future research should ascertain if PETH
concentration in DBS samples between 2 and 8 ng/ml should be
considered as light alcohol use and ≥8 ng/ml should be
considered moderate to heavy alcohol use in pregnancy.12 For
this study we used the cutoff of ≥8 ng/ml based on several
previous reports suggesting the limit of quantiﬁcation (LOQ)
indicated any alcohol use.12,14,16,22,23 A previous validation article
notes that this cutoff has 100% speciﬁcity and lower but
comparable sensitivity to other methodologies to detect moder-
ate chronic or intermittent binge drinking patterns during
pregnancy.27 Although some researchers utilize a higher cutoff
of ten times the LOD (>20 ng/ml) for identifying late pregnancy
PAE,13,28 this higher cutoff was recommended for liquid blood
specimens for the general population and not for the newborn
population alone.22 In liquid blood samples the post-collection
synthesis of PETH may occur if ethanol is present in the blood
sample, resulting in false-positive results. However, no post-
collection synthesis of PETH occurs in the DBS samples,22,27 and
false-positive results are not possible without alcohol use; thus, it
can be argued that any concentration above the LOD indicates
alcohol use in late pregnancy.12,29 As there is no consensus on
what the “ideal” cutoff is for newborns and no reports have
identiﬁed false-positive PETH results without alcohol consump-
tion, this study used a cutoff of ≥8 ng/ml (0.288 μmol/l) to identify
any alcohol exposure 2–4 weeks prior to data collection.30
Associated factors
The signiﬁcant factors associated with PAE include smoking
during pregnancy, LBW, gestational age, and breastfeeding. These
ﬁndings are consistent with previous literature.31–33 Regarding
preterm birth, the results showed that the odds of having a
preterm birth among the prenatal alcohol use group nearly
doubled compared to the no alcohol use group. For the birth
weight variable, PAE (vs. no PAE) was signiﬁcantly associated with
LBW of ≤2000 g compared to the referent group of >3000 g. Two
additional birth weight categories that include 2000–2500 g and
2501–3000 g were not statistically signiﬁcantly associated with
PAE compared to the referent group category of >3000 g.
However, when the study was restricted to full-term birth infants
only, the association between LBW of ≤2000 g compared to
>3000 g became statistically not signiﬁcant. Moreover, small for
gestational age (SGA) vs. appropriate for gestational age (AGA)
was also not a statistically signiﬁcant factor associated with PAE.
Previous studies have also shown mixed results regarding the
association between PAE and preterm birth or SGA. Some studies
have shown that there is no association between low to moderate
PAE and SGA34 while others have shown there is an increased risk
of SGA births in mothers who drink ≥3 units/day of alcohol in
pregnancy.35 Our study is restricted to maternal alcohol use
2–4 weeks before delivery as well as having no data on the
amount of alcohol consumption. Therefore, we were unable to
assess or compare our ﬁndings to other studies that capture the
amount of alcohol consumption at various time points throughout
pregnancy.
Regional prevalence
The six substate SAMSHA regional data for WV showed
geographical disparities in the prevalence of late pregnancy PAE
in WV. The mid-Ohio Valley Region 3 had one of the highest
prevalence of late pregnancy PAE in the state. Our earlier work on
IUSE in 2017 showed that Region 1, the northern panhandle
region had one of the highest rates of IUSE (18.49%).36 In our
current study, Region 3 ranked highest in PAE (17.11%) and ﬁfth in
IUSE (13.16%).
These disconcerting results led the research team to perform
post-hoc analyses to determine if the linked IUSE data as reported
by the statewide surveillance system (Project WATCH) at birth
captured any, none, or all of the alcohol use (PETH) data. The results
of the post-hoc analysis revealed that the substance use data did
not capture more than 90% of the alcohol cases. The IUSE data in
Project WATCH collects information from three sources, (1) self-
report, (2) documented in the past medical records, or/and (3)
positive drug screen. Self-reported alcohol use in pregnancy has low
sensitivity and maternal blood, breath, or urine maybe only useful to
detect recent alcohol exposure,11 demonstrating the challenges
associated with timely identiﬁcation and detection of PAE.
Further exploration into the demographic characteristics of the
study population by regions showed that Region 3 consists of 97%
White population, nearly 8% teenage pregnancies, and approxi-
mately 10% of the mothers had ≤10 grade of high school
education. However, in the overall data for all births in the state,
we observed that maternal race, age, and education were not
statistically signiﬁcantly associated with alcohol use in late
pregnancy. Thus, at this point a follow-up study is required to
understand the regional differences.
Limitations of the study include some of the reasons discussed
earlier for differences in hypothesized prevalence rates: i.e., PETH
is a direct alcohol biomarker, which indicates late pregnancy. PETH
in the DBS is relatively stable over time if it is stored at lower
temperatures.15 However, the DBS in our study were stored and
shipped at room temperatures and analyzed for PETH after
approximately 8 months, which likely resulted in a small amount
Table 3. Descriptive characteristics of maternal factors at time of delivery in percentages (%) by SAMHSA regions (N= 1471).
SAMSHA
regions
Age (≤19) Race
(White)
Education
(≤10 grade)
Health insurance
(Medicaid)
No. of previous
pregnancy (none)
Alcohol use Smoking Substance use
State 6.73% 91.29% 8.43% 54.25% 27.80% 7.61% 21.26% 15.30%
1 5.43% 92.22% 3.26% 26.74% 25.00% 7.61% 28.26% 21.74%
2 6.82% 82.95% 9.85% 63.08% 26.52% 2.27% 17.42% 19.70%
3 7.89% 97.30% 9.87% 56.76% 31.58% 17.11% 21.05% 13.16%
4 4.95% 92.18% 8.79% 47.34% 33.52% 4.67% 18.41% 13.46%
5 6.84% 88.73% 6.60% 56.06% 25.00% 6.37% 18.87% 12.97%
6 8.47% 94.08% 10.75% 63.05% 24.43% 10.42% 29.32% 17.92%
Region 1: Brooke, Hancock, Marshall, Ohio, Wetzel
Region 2: Berkeley, Grant, Hampshire, Hardy, Jefferson, Mineral, Morgan, Pendleton
Region 3: Calhoun, Jackson, Pleasants, Ritchie, Roane, Tyler, Wirt, Wood
Region 4: Barbour, Braxton, Doddridge, Gilmer, Harrison, Lewis, Marion, Monongalia, Preston, Randolph, Taylor, Tucker, Upshur
Region 5: Boone, Cabell, Clay, Kanawha, Lincoln, Logan, Mason, Mingo, Putnam, Wayne
Region 6: Fayette, Greenbrier, McDowell, Mercer, Monroe, Nicholas, Pocahontas, Raleigh, Summers, Webster, Wyoming
Bold: State averages and the highest region for each factor
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of PETH degradation, consistent with Bakhireva et al.’s 2016
ﬁndings, which found temperature but not time minimally
impacting PETH degradation over a 9-month period.15 Moreover,
samples were collected in 3 months of November, December, and
January and may have inﬂuenced the prevalence and the
comparability to other samples collected over broad calendar
periods, under the assumption that holiday drinking patterns
could be higher than non-holidays drinking pattern. Additionally,
the literature shows that there is no gold standard for detecting
PAE and combining different screening tools and methods are
needed to ﬁnd the true prevalence rates in a population.23 Bracero
et al. concluded that self-report, urine ethanol, and PETH testing
combined identiﬁed more PAE cases than any single method.23
However, our study only used PETH in the infant residual DBS, and
thus may have underestimated the prevalence rate. Finally, due to
a lack of standardized PETH concentration cutoff, comparing the
rates of PAE using DBS is difﬁcult across studies. Although not the
main purpose of this study, we were unable to assess the
association for some of the main predictors of PAE such as pre-
pregnancy alcohol consumption and exposure to abuse or
violence37 due to lack of available data. Moreover, based on one
peer-review comment, an additional post-hoc analysis was
conducted to determine the association between PAE and
preterm birth by infant’s sex. As further examining this association
is beyond the scope of this study, we recommend future research
to examine the association between PAE and preterm birth
stratiﬁed by infant’s sex.
This study demonstrates that the rates of late pregnancy PAE in
WV are high. Moreover, the detection of PETH in residual DBS was
found to be an effective surveillance method to monitor rates of
PAE for a broad epidemiological study.22 Comparisons against
other methods showed improved prevalence estimates; however,
using the LOQ for PETH likely still underestimates the true
prevalence of any drinking during pregnancy. Analysis of the PETH
data in conjunction with the statewide surveillance system
(Project WATCH) identiﬁed many factors associated with PAE.
Nearly 1 in 13 women in the state of WV drank alcohol in the last
few weeks of pregnancy. Some substate regions experience as
high as 1 in 6 women drinking alcohol in late pregnancy. The
average number of births/year (2014−2018) for the state of WV is
~19,500 (SD= 1000.34), and an 8% PAE prevalence rate theore-
tically means that 1500 babies may have been exposed and at a
risk of developing FASD. The prevalence estimates of late
pregnancy PAE are alarming due to its association with the FASD
and thus the ﬁndings of our study highlight the potential public
health burden associated with PAE in WV as observed in four
varying regions of the country as well.6
PAE is a serious public health problem. Developmental disabilities
resulting from FASD are preventable and have high associated
economic and societal costs.38 The effects of FASD may not always
be apparent at birth; for conditions and complications developing
later, such as at school age, it becomes increasingly likely that
conditions due to FASD will be misdiagnosed or missed
altogether.39 Knowing the true extent of the problem in a timely
manner is the ﬁrst step in identifying what resources and services
are needed for primary, secondary, and tertiary prevention of this
critical public health issue. Early detection of PAE and early diagnosis
and intervention of FASD can prevent secondary disabilities and
improve infant’s outcomes and the quality of life.14,40
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